Opendata, web and dolomites

SweetBrain SIGNED

A new perspective on the metabolic pathway to neuronal dysfunction: Using organs on a chip to elucidate the role of the brain microvasculature

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SweetBrain project word cloud

Explore the words cloud of the SweetBrain project. It provides you a very rough idea of what is the project "SweetBrain" about.

hypothesize    levels    regarding    elusive    human    relationship    illuminating    diabetic    coupled    scarcity    correlated    glucose    coupling    suggest    little    chip    perspective    primarily    vasculature    brain    crosstalk    cure    diseases    functionally    communications    metabolically    revealed    ignoring    modeling    astrocytes    populations    cns    altering    neurodegenerative    fundamental    neurons    capacity    separately    treatment    direct    elucidate    unexplored    remaining    homeostasis    cell    questions    nervous    cutting    unconsidered    hyperglycemia    ooc    neurodegeneration    subsequently    functional    grow    endothelium    diminish    hypothesis    limitations    pass    metabolites    interactions    pointing    drawing    despite    observations    central    mechanisms    clear    gatekeeper    nvu    underpinnings    function    types    previously    models    metabolism    overcomes    vein    mainly    physiology    neuronal    edge    metabolic    model    dysfunction    decades    drives    revolutionize    organ    neurovascular    thereby    disease   

Project "SweetBrain" data sheet

The following table provides information about the project.

Coordinator
TEL AVIV UNIVERSITY 

Organization address
address: RAMAT AVIV
city: TEL AVIV
postcode: 69978
website: http://www.tau.ac.il/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 1˙487˙438 €
 EC max contribution 1˙487˙438 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-07-01   to  2025-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TEL AVIV UNIVERSITY IL (TEL AVIV) coordinator 1˙487˙438.00

Map

 Project objective

Despite decades of research, the underpinnings of central nervous system (CNS) diseases and clear pathways to effective treatment remain elusive, mainly because of a scarcity of adequate models and methods with the capacity to elucidate human brain physiology. Recent studies suggest that high glucose levels are correlated with neuronal dysfunction and neurodegeneration, yet very little is known about the mechanisms of this relationship. Research in this vein has focused primarily on direct metabolic interactions between neurons and astrocytes, ignoring other cell populations in the neurovascular unit (NVU) that might have a meaningful role. My recent research revealed that the brain vasculature—the ‘gatekeeper’ through which all metabolites must pass to reach the neurons—has direct metabolic coupling with the neurons. Drawing from these observations, I adopt a previously unconsidered perspective and propose that the vasculature drives the neurodegenerative effects of hyperglycemia. Specifically, I hypothesize that high glucose levels change the metabolic function of the brain vasculature, thereby altering the direct endothelium-neuronal crosstalk and triggering neuronal dysfunction. To investigate this hypothesis, I will develop cutting-edge Organ-on-a-Chip (OoC) technology that overcomes the limitations of modeling NVU functionality and cell-cell interactions. Specifically, I will: (1) establish a human-relevant NVU-OoC model for metabolic and functional interactions, in which different cell types grow separately while remaining metabolically and functionally coupled; (2) identify the major metabolic and functional interactions in the human NVU at homeostasis and under diabetic conditions; and subsequently (3) target the vasculature communications to diminish neuronal dysfunction. This research has the potential to revolutionize the study of CNS disease, pointing to an unexplored pathway to a cure, and illuminating fundamental questions regarding brain metabolism.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SWEETBRAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SWEETBRAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

KineTic (2020)

New Reagents for Quantifying the Routing and Kinetics of T-cell Activation

Read More  

CARBYNE (2020)

New carbon reactivity rules for molecular editing

Read More  

SWIP (2019)

Extended short-wave infrared pulsed fibre laser

Read More